Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Sudbeck

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Idrugs : the Investigational Drugs Journal|August 25, 2005
Recent advances in JAK3 kinase inhibitorsE A Sudbeck, F M Uckun
Antiviral Chemistry & Chemotherapy|November 26, 1999
Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virusC Mao, E A Sudbeck, T K Venkatachalam, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virusC Mao, E A Sudbeck, T K Venkatachalam, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|January 21, 2000
Inhibitor of HIV-1 reverse transcriptase: N'-(5-bromo-2-pyridyl)-N-[2-(2,5-dimethoxyphenyl)ethyl]thioureaE A Sudbeck, J D Jennissen, T K Venkatachalam, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptaseT K Venkatachalam, E A Sudbeck, C Mao, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compoundsT K Venkatachalam, E A Sudbeck, C Mao, et al.
Biochemical Pharmacology|September 29, 2000
Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptaseC Mao, E A Sudbeck, T K Venkatachalam, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|October 12, 2000
An inhibitor of Janus kinase 3:4-(4-hydroxyphenylamino)-6, 7-dimethoxyquinazolin-1-ium chloride methanol solvateE A Sudbeck, J D Jennissen, X P Liu, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptaseC Mao, R Vig, T K Venkatachalam, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO seriesR Vig, C Mao, T K Venkatachalam, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Idrugs : the Investigational Drugs Journal|August 25, 2005
Recent advances in JAK3 kinase inhibitorsE A Sudbeck, F M Uckun
Antiviral Chemistry & Chemotherapy|November 26, 1999
Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virusC Mao, E A Sudbeck, T K Venkatachalam, et al.
Bioorganic & Medicinal Chemistry Letters|July 1, 1999
Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virusC Mao, E A Sudbeck, T K Venkatachalam, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|January 21, 2000
Inhibitor of HIV-1 reverse transcriptase: N'-(5-bromo-2-pyridyl)-N-[2-(2,5-dimethoxyphenyl)ethyl]thioureaE A Sudbeck, J D Jennissen, T K Venkatachalam, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2000
Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptaseT K Venkatachalam, E A Sudbeck, C Mao, et al.
Bioorganic & Medicinal Chemistry Letters|March 7, 2001
Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compoundsT K Venkatachalam, E A Sudbeck, C Mao, et al.
Biochemical Pharmacology|September 29, 2000
Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptaseC Mao, E A Sudbeck, T K Venkatachalam, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|October 12, 2000
An inhibitor of Janus kinase 3:4-(4-hydroxyphenylamino)-6, 7-dimethoxyquinazolin-1-ium chloride methanol solvateE A Sudbeck, J D Jennissen, X P Liu, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptaseC Mao, R Vig, T K Venkatachalam, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO seriesR Vig, C Mao, T K Venkatachalam, et al.
Pageof 3